How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Cibinqo cost savings if eligible
If you are eligible for the Cibinqo patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Cibinqo prescription for just $49 a month, regardless of the retail price of your medication.
Am I eligible for the Cibinqo patient assistance program?
We will review your application to determine whether you are eligible for the Cibinqo patient assistance program. Each program has its own eligibility criteria which is set by the pharmaceutical companies, however the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Cibinqo patient assistance program?
We make it as easy as possible to apply for the Cibinqo patient assistance program. The first step is to complete our enrollment application. Tell us about any medications you are taking, including Cibinqo. We will also ask for details about your healthcare provider, insurance, and your household income. This information is required by the pharmaceutical manufacturers who ship your medication.
If we determine that you may be eligible for Cibinqo assistance, we will handle the application process for you. We will work directly with your healthcare provider to prepare your application documents. Once we have received the signed application and supporting documents, we will submit them to the patient assistance program on your behalf. Our service continues once you are enrolled in the Cibinqo patient assistance program, and we will automatically request your Cibinqo medication refills for up to 1 year.
Is NiceRx a Cibinqo coupon provider?
We are a service provider that helps eligible individuals access the Cibinqo patient assistance program. That means that we do not offer printable Cibinqo manufacturer coupons, Cibinqo discounts, or free Cibinqo samples. We are not a Cibinqo coupon provider or Cibinqo discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.
Can NiceRx help me get Cibinqo cheaper if I have insurance?
We may be able to help you to access Cibinqo patient assistance in a variety of circumstances. This includes when your insurance company will not pay for your Cibinqo medication or if you have a high copay or coinsurance responsibility. We may also be able to help you if you do not have insurance. Please apply online to find out more.
How much does Cibinqo cost without insurance?
Cibinqo cost without insurance will vary depending on where you buy it. As a guide, Cibinqo oral tablets 50 mg usually cost $5,200 for 30 tablets. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.
How much does Cibinqo cost with insurance?
The copay for Cibinqo with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.
What is Cibinqo?
Cibinqo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Pfizer Inc. Cibinqo is a Janus kinase (JAK1) inhibitor used to treat adults with refractory, moderate-to-severe atopic dermatitis (eczema) whose disease is not controlled well enough with other drugs, including biologics, or when the use of other treatments is not recommended. Cibinqo is not recommended to be used with other JAK inhibitors, biologics, or other immunosuppressants. Cibinqo can be used as monotherapy or with topical corticosteroids for atopic dermatitis.
What doses of Cibinqo are available?
Cibinqo is available in tablet form, in the following doses: 50 mg, 100 mg, and 200 mg.
The recommended dose is 100 mg once daily. Patients with moderate renal impairment take 50 mg once daily. Patients who are CYP2C19 poor metabolizers should take 50 mg once daily. Do not take Cibinqo with other drugs that prevent blood clots during the first 3 months of treatment.
You are advised to limit the time you spend in sunlight. Avoid tanning beds or sunlamps and wear protective clothing when you are outside. Use sunscreen, SPF 30 and above.
See the full prescribing information for the complete boxed warning, read the labeling provided with your medicine, and always speak with a healthcare professional for medical advice about any changes to your dose so they can monitor and evaluate your condition.
Cibinqo active ingredients
Cibinqo contains abrocitinib as the active ingredient.
Cibinqo side effects
The most common side effects of Cibinqo in clinical trials compared to placebo include:
- Nausea, vomiting, headache, dizziness
- Herpes simplex, herpes zoster
- Increased blood creatinine phosphokinase
- Urinary tract infection
- Oropharyngeal pain, influenza
- Contact dermatitis
- Upper abdominal pain, abdominal discomfort
In rare instances, Cibinqo can cause more serious side effects. These can include:
- Deep vein thrombosis and pulmonary embolism
- Increased mortality
- Major adverse cardiovascular events
- Laboratory abnormalities – monitoring is recommended due to potential changes in platelets, lymphocytes, and lipids
- Increased risk of serious infections
Your doctor will assess the benefits of using Cibinqo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Cibinqo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Cibinqo drug interactions
Cibinqo can interact with other medications. These include:
- Strong inhibitors of CYP2C19 and CYP2C9
- Strong CYP2C19 or CYP2C9 inducers
- Immunizations: – avoid the use of live vaccines before, during, and immediately after treatment with Cibinqo
This list is not exhaustive and other prescription drugs may interact with Cibinqo.
You should not use Cibinqo if you:
- Are allergic to the active ingredient abrocitinib
- Are allergic to any of the other ingredients in Cibinqo
- Are using antiplatelet therapies except for low-dose aspirin, during the first 3 months of treatment
- Are pregnant or are planning to become pregnant
Talk to your doctor before using Cibinqo if you:
- Are taking any of the medications that could interact with Cibinqo
- Have renal impairment or end-stage renal disease
- Have hepatic Impairment
- Are being treated for an infection or have an infection that does not go away or that keeps coming back
- Have diabetes
- Have chronic lung disease
- Have HIV or a weak immune system
- Have TB or have been in close contact with someone with TB
- Have had shingles (herpes zoster)
- Have had hepatitis B or hepatitis C
- Live or have lived or traveled to parts of the country where there is an increased risk of getting certain kinds of fungal infections
- Are breastfeeding or are planning to breastfeed
Cibinqo is the trademark brand name for abrocitinib manufactured by Pfizer Inc. A generic version of abrocitinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Cibinqo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.